Research Use Only
Explore neural cell models, gene-engineered and disease-focused systems, and custom neuroscience tools for mechanism studies, target validation, screening, neurotoxicity, and neural-circuit research—supported by product-to-assay matching and scientific consultation.
One portfolio, multiple routes to the right model
Start with the attribute that defines your study most clearly. The same project may combine a disease background, a specific neural lineage, and a targeted genetic modification; our team can help reconcile those requirements before product selection.
Investigate gene function, disease-associated variants, gain- or loss-of-function mechanisms, protein localization, and target engagement using models organized around neuroscience-relevant genes and defined engineering strategies.
Choose wild-type, iPSC-derived, immortalized, Cas9-ready, reporter, knockout, knock-in, or overexpression neural models according to biological relevance, scalability, editing strategy, and readout requirements.
Match cellular systems to neurodegenerative, neuromuscular and genetic, autoimmune and inflammatory, pain and functional, structural and developmental, rare and metabolic, or other neurological disease research.
Support neural labeling, tracing, manipulation, identification, reprogramming, direct conversion, and signaling studies with custom-prepared viral vectors, neuronal marker antibodies, neuroactive peptides, neuromodulating compounds, optogenetic tools, factors, and cell lines.
Specify species, donor or disease background, neural lineage, maturation state, and whether a monoculture, co-culture, or more complex model is required.
Identify the gene, variant, knockout, knock-in, overexpression, reporter, compound exposure, or circuit-level manipulation central to the hypothesis.
Match the product to imaging, marker analysis, viability, electrophysiology, signaling, differentiation, target-validation, or screening endpoints.
Select an appropriate wild-type, parental, isogenic, vehicle, or untreated control to make the experimental contrast interpretable.
A structured exchange helps connect the research question to an available product or a custom development path without assuming that one model fits every endpoint.
Research objective, disease area, cell background, genetic feature, assay format, and intended readouts.
Compare biological relevance, control strategy, experimental compatibility, and available characterization.
Finalize the selected product, supporting materials, quantities, or the requirements for a custom solution.
Coordinate product documentation, use considerations, and any agreed technical consultation for study initiation.
Examine disease-associated cellular phenotypes, pathway dysregulation, protein processing, neuronal stress, and neuron-glia interactions.
Use defined genetic perturbations and matched controls to test causal relationships between a target and a neural phenotype.
Select scalable neural models and reporter-compatible systems for primary screening, follow-up studies, or mechanism-focused evaluation.
Evaluate effects on neural viability, morphology, differentiation, signaling, or functional endpoints in a relevant cellular context.
Combine viral vectors, optogenetic actuators or indicators, antibodies, and other tools for labeling, tracing, manipulating, and monitoring neural systems.
Study neural induction, lineage specification, maturation, synaptogenesis, reprogramming, and direct cellular conversion.
Why Neurost
A useful neuroscience product is defined by how well its biology, perturbation, comparator, and readout answer the same research question. Neurost brings those decisions into one product-selection conversation.
Review My Study RequirementsNavigate by disease, gene, cell type, or research-tool function, then connect overlapping requirements instead of treating each category as an isolated choice.
Evaluate iPSC-derived, primary, immortalized, engineered, and reporter systems against biological relevance, scalability, assay duration, and throughput.
Align knockout, knock-in, overexpression, Cas9-ready, reporter, or disease-background models with a suitable wild-type, parental, or isogenic comparison.
Discuss compatibility with imaging, marker analysis, calcium assays, electrophysiology, neurotoxicity testing, high-content analysis, or phenotypic screening before the study begins.
Projects can begin with an existing catalog category or with a discussion of a model or research tool that requires a specific genetic feature, cellular background, preparation, or compatible readout. The inquiry form is the fastest way to provide those selection criteria for review.
Scientific context for product selection
The literature below frames four decisions that shape a useful neuroscience model: mechanism, lineage, biological complexity, and functional readout. These papers provide external scientific context and are not presented as Neurost performance data.
Puri and colleagues review shared and disease-associated molecular targets. The paper supports matching cell background, genetic perturbation, and readout to a specific mechanism rather than selecting by diagnosis alone.
Puri, Vivek, et al. “Natural Product-Based Pharmacological Studies for Neurological Disorders.” Frontiers in Pharmacology, vol. 13, 2022, article 1011740. https://doi.org/10.3389/fphar.2022.1011740
Vaz, Ribeiro, and Pinto synthesize neurogenic regions and cellular stages. Their review is relevant when choosing neural stem cells, progenitors, differentiated neurons, lineage markers, or reporter systems.
Vaz, Andreia, Inês Ribeiro, and Luísa Pinto. “Frontiers in Neurogenesis.” Cells, vol. 11, no. 22, 2022, article 3567. https://doi.org/10.3390/cells11223567
Nishimura and coauthors discuss human brain models from cellular systems to organoids. The review supports selecting the level of complexity according to the biological interactions the experiment must preserve.
Nishimura, Kohei, et al. “Recent Advances and Applications of Human Brain Models.” Frontiers in Neural Circuits, vol. 18, 2024, article 1453958. https://doi.org/10.3389/fncir.2024.1453958
Smedemark-Margulies and Trapani survey genetically encoded sensors, photoactuators, expression methods, and applications, providing a basis for matching optical tools with delivery and functional readouts.
Smedemark-Margulies, Niklas, and Josef G. Trapani. “Tools, Methods, and Applications for Optophysiology in Neuroscience.” Frontiers in Molecular Neuroscience, vol. 6, 2013, article 18. https://doi.org/10.3389/fnmol.2013.00018
Fill out the form below, and our expert team will contact you to design your custom project and accelerate breakthrough innovations.
